Changing Diabetes in Children (CDiC) programme

Changing Diabetes® in Children as a public-private partnership programme that consolidates efforts to address barriers to healthcare, supporting the development of comprehensive and sustainable diabetes care structures together with national governments, key opinion leaders, diabetes associations and other implementing partners.


Childhood diabetes has a high mortality rate in poor and developing countries. The International Diabetes Federation (IDF) estimates that there are 600,900 children under the age of 15 years living with type 1 diabetes worldwide.1 About half of them live in low- and middle-income countries. Type 1 diabetes in children and young people often goes unnoticed, especially in these countries.

Even if diagnosed, only few have sufficient access to insulin, blood glucose monitoring equipment, and education and potentially die as a result. According to experts, life expectancy is often less than a year after diagnosis.

What we’re doing

The Changing Diabetes in Children programme is structured around four key components aimed at building a holistic and sustainable care system:

Patient education and advocacy
  • > 228,000 in-clinic patient education sessions, adapted to children and adolescents, have been conducted.

  • > 12,000 children have attended educational camps.

Training of healthcare professionals
  • 25,314 healthcare professionals have been trained to diagnose and treat type 1 diabetes in low-resource settings.

  • 2,267 healthcare professionals have received advanced training.

Support the establishment of national clinics
  • >470 clinics have been established or refurbished, as an integrated part of national healthcare systems, ensuring coverage in rural and remote areas.

Medical supplies and cold chains
  • > 3.8 million vials of insulin have been donated along with blood glucose monitoring equipment and medical supplies, while national supply chains have been strengthened through the establishment of cold chains.

What's next for Changing Diabetes in Children?

Changing Diabetes in Children, with the support of global and local partners, will continue to ensure access to comprehensive high-quality diabetes therapy for children and adolescents living with type 1 diabetes in low- and middle income settings. Changing Diabetes in Children will also continue to raise awareness about type 1 diabetes and advocate for access to quality essential healthcare services as well as finding sustainable solutions to strengthen diabetes care.

Roche Diabetes Care extended its partnership with Novo Nordisk at the end of 2020. Since its launch in 2009, the public-private partnership program has improved the lives of more than 54,000 children and aims to reach a total of 100,000 children and adolescents living with diabetes by 2030.


  1. Type 1 diabetes estimates in children and adults – 2022 |


Roche’s commitment to sustainable healthcare.Roche’s Contribution to the UN’s Millennium Development Goals

Discover more

Roche Diabetes Care - United we manage diabetes betterNo child should die of diabetes - Changing Diabetes in Children
See more access stories

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement